Vaccine Development: the Potential of the Butantan Institute in the Covid-19 Pandemic Scenario

• Autor(a) principal: Pazelli, Gabriela Simões
• Data de Publicação: 2022
• Outros Autores: Chudzinski-Tavassi, Ana Marisa, Vasconcellos, Alexandre Guimaraes
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Cadernos de Prospecção (Online)
• Texto Completo: https://periodicos.ufba.br/index.php/nit/article/view/48379
• topic: Covid-19; Transferência de Tecnologia; Vacinas.; COVID-19; Technology transfer; Vaccines.

Vaccines' development and production capacity are essentials in the fight against diseases. This process becomes urgent during pandemics, such as Covid-19, with very high death numbers. This study aims to clarify how the technology transfer strategy applied in Brazil, applied by Instituto Butantan, benefits the vaccine development. Using documentary research, this work addresses the challenges faced in vaccine production. The structure already installed at Butantan was essential for its role in the face of Covid-19, as the adopted partnerships and the use of knowledge already acquired stand out. The use of technologies already mastered speeds up the product development process and reduces financial investment, and fully national production contributes to reversing its situation of technological vulnerability. For these initiatives to continue, a policy for investments in the health industrial complex is essential, and support for projects and personnel involved in RD&I at the institution and in Brazil.